Temple University Hospital
Hematology and Oncology fellowship · Philadelphia, PA · Temple University Hospital programs · Program website
Internal Medicine residency here · Other fellowships: Rheumatology · Cardiovascular Disease · Gastroenterology · Pulmonary and Critical Care · Nephrology · Infectious Disease · Endocrinology, Diabetes, and Metabolism
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Temple University Hospital's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
Hematology and Oncology at Temple University Hospitalshared by every program there, not this program's own
Institution-level: all hematology and oncology publications from Temple University Hospital and affiliated institutions, since 2022. Updated 2026-11-08; refreshed daily.
Works per year · * 2026 so far
Hematology and Oncology research topics at Temple University Hospital
Papers in the window; each links to the list on OpenAlex.
Most cited at Temple University Hospital since 2024
All hematology and oncology papers there on OpenAlex
- DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervixYoung Kwang Chae et al. · Journal for ImmunoTherapy of Cancer · 2026 · PubMed · cited 5
- A Systematic Review and Meta-Analysis of Radiation Necrosis Incidence in Brain Metastasis Treated by Gamma Knife and CyberKnife Stereotactic RadiosurgeryH. Bradley Walker et al. · World Neurosurgery · 2025 · PubMed · cited 7
- Transfusion of Amustaline/Glutathione Pathogen-reduced Red Blood Cells in Cardiac Surgery: A Randomized Phase 3 Clinical TrialMichael E. Sekela et al. · Anesthesiology · 2025 · PubMed · cited 9
- A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar CancersYoung Kwang Chae et al. · Clinical Cancer Research · 2024 · PubMed · cited 9
- SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian CancerYoung Kwang Chae et al. · Clinical Cancer Research · 2024 · PubMed · cited 13
- Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancerRemziye E. Wessel et al. · Journal for ImmunoTherapy of Cancer · 2024 · PubMed · cited 21
- Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumorsYoung Kwang Chae et al. · Journal for ImmunoTherapy of Cancer · 2024 · PubMed · cited 10
- Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunitiesParth Anil Desai et al. · Cell Reports Medicine · 2024 · PubMed · cited 44
- Utilizing Data from Electrical Impedance Spectroscopy Significantly Improves the Decision to Biopsy Pigmented Skin Lesions Beyond Clinical Evaluation and DermoscopyDanny Zakria et al. · SKIN The Journal of Cutaneous Medicine · 2024 · cited 6
- Association of Social Determinants with Patient-Reported Outcomes in Patients with CancerHollis Hutchings et al. · Cancers · 2024 · PubMed · cited 13
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/temple-university-hospital-heme-onc"><img src="https://openprograms.org/programs/temple-university-hospital-heme-onc/badge.svg" alt="Temple University Hospital Hematology and Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.